Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases (Q43420356)

23 November 2017

title

Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases (English)

1 reference

23 November 2017

1 reference

Frank Makowiec

1

1 reference

23 November 2017

Simone Möhrle

2

1 reference

23 November 2017

Hannes Neeff

3

1 reference

23 November 2017

Oliver Drognitz

4

1 reference

23 November 2017

Gerald Illerhaus

5

1 reference

23 November 2017

Oliver G Opitz

6

1 reference

23 November 2017

Ulrich T Hopt

7

1 reference

23 November 2017

Axel zur Hausen

8

1 reference

23 November 2017

publication date

1 January 2011

1 reference

Journal of Gastrointestinal Surgery

23 November 2017

published in

1 reference

23 November 2017

volume

15

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

153-164

1 reference

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Impact of steatosis on perioperative outcome following hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Hepatic steatosis as a potential risk factor for major hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1368-7

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases

21 January 2018

1 reference

12 December 2020

R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

1 reference

12 December 2020

Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases

1 reference

12 December 2020

Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome

1 reference

12 December 2020

Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade

1 reference

12 December 2020

Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy

1 reference

12 December 2020

Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?

1 reference

12 December 2020

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

12 December 2020

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival

1 reference

12 December 2020

10.1007/S11605-010-1368-7

Identifiers

DOI

1 reference

23 November 2017

1 reference